This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gudmundsson, J. Articles by Barkardottir, R. B. Search for Related Content PubMed PubMed Citation Articles by Gudmundsson, J. Articles by Barkardottir, R. B.

Different Tumor Types from BRCA2 Carriers Show Wild-Type Chromosome Deletions on 13q12–q13¹

Department of Pathology, Division of Cell Biology, House 14, University Hospital of Iceland, IS-121 Reykjavik, Iceland

In this study we examined loss of heterozygosity (LOH) on chromosome 13q12–13 in 50 tumors from BRCA2 carriers in five families showing strong evidence of linkage to BRCA2. In addition to high frequency of LOH in female breast cancer, LOH was observed in tumors of the prostate, ovary, cervix, colon, male breast, and ureter. All detected losses involved the wild-type chromosome. These results suggest that BRCA2 is a tumor suppressor gene and may be involved in the tumorigenesis of several cancer types in addition to breast cancer.

¹ This work was supported by the Nordic Cancer Union, the Science Fund of Iceland, the University of Iceland Graduate Research Fund, the Science Fund of the University Hospital of Iceland, and the Memorial Fund of Bergthora Magnusdottir and Jakob B. Bjarnason.

² To whom requests for reprints should be addressed.

Received 8/ 4/95. Accepted 9/19/95.

This article has been cited by other articles:

				A. J. Willems, S.-J. Dawson, H. Samaratunga, A. De Luca, Y. C. Antill, J. L. Hopper, H. J. Thorne, and and kConFab Investigators Loss of Heterozygosity at the BRCA2 Locus Detected by Multiplex Ligation-Dependent Probe Amplification is Common in Prostate Cancers from Men with a Germline BRCA2 Mutation Clin. Cancer Res., May 15, 2008; 14(10): 2953 - 2961. [Abstract] [Full Text] [PDF]

				E. M. Swisher, W. Sakai, B. Y. Karlan, K. Wurz, N. Urban, and T. Taniguchi Secondary BRCA1 Mutations in BRCA1-Mutated Ovarian Carcinomas with Platinum Resistance Cancer Res., April 15, 2008; 68(8): 2581 - 2586. [Abstract] [Full Text] [PDF]

				F. Meric-Bernstam Heterogenic Loss of BRCA in Breast Cancer: The "Two-Hit" Hypothesis Takes a Hit Ann. Surg. Oncol., September 1, 2007; 14(9): 2428 - 2429. [Full Text] [PDF]

				T. A. King, W. Li, E. Brogi, C. J. Yee, M. L. Gemignani, N. Olvera, D. A. Levine, L. Norton, M. E. Robson, K. Offit, et al. Heterogenic Loss of the Wild-Type BRCA Allele in Human Breast Tumorigenesis Ann. Surg. Oncol., September 1, 2007; 14(9): 2510 - 2518. [Abstract] [Full Text] [PDF]

				G. Chenevix-Trench, S. Healey, S. Lakhani, P. Waring, M. Cummings, R. Brinkworth, A. M. Deffenbaugh, L. A. Burbidge, D. Pruss, T. Judkins, et al. Genetic and Histopathologic Evaluation of BRCA1 and BRCA2 DNA Sequence Variants of Unknown Clinical Significance Cancer Res., February 15, 2006; 66(4): 2019 - 2027. [Abstract] [Full Text] [PDF]

				L. Moro, A. A. Arbini, E. Marra, and M. Greco Down-regulation of BRCA2 Expression by Collagen Type I Promotes Prostate Cancer Cell Proliferation J. Biol. Chem., June 10, 2005; 280(23): 22482 - 22491. [Abstract] [Full Text] [PDF]

				J. Lorenzo Bermejo and K. Hemminki Risk of cancer at sites other than the breast in Swedish families eligible for BRCA1 or BRCA2 mutation testing Ann. Onc., December 1, 2004; 15(12): 1834 - 1841. [Abstract] [Full Text] [PDF]

				H.-R. Lin, N. S. Y. Ting, J. Qin, and W.-H. Lee M Phase-specific Phosphorylation of BRCA2 by Polo-like Kinase 1 Correlates with the Dissociation of the BRCA2-P/CAF Complex J. Biol. Chem., September 19, 2003; 278(38): 35979 - 35987. [Abstract] [Full Text] [PDF]

				E Kwiatkowska, I Brozek, E Izycka-Swieszewska, J Limon, and A Mackiewicz Novel BRCA2 mutation in a Polish family with hamartoma and two male breast cancers J. Med. Genet., July 1, 2002; 39(7): e35 - 35. [Full Text] [PDF]

				N. Hu, G. Li, W.-J. Li, C. Wang, A. M. Goldstein, Z.-Z. Tang, M. J. Roth, S. M. Dawsey, J. Huang, Q.-H. Wang, et al. Infrequent Mutation in the BRCA2 Gene in Esophageal Squamous Cell Carcinoma Clin. Cancer Res., April 1, 2002; 8(4): 1121 - 1126. [Abstract] [Full Text] [PDF]

				L. Savelyeva, A. Claas, I. Matzner, P. Schlag, W. Hofmann, S. Scherneck, B. Weber, and M. Schwab Constitutional Genomic Instability with Inversions, Duplications, and Amplifications in 9p23-24 in BRCA2 Mutation Carriers Cancer Res., July 1, 2001; 61(13): 5179 - 5185. [Abstract] [Full Text] [PDF]

				P. Geck, M. V. Maffini, J. Szelei, C. Sonnenschein, and A. M. Soto Androgen-induced proliferative quiescence in prostate cancer cells: The role of AS3 as its mediator PNAS, August 29, 2000; 97(18): 10185 - 10190. [Abstract] [Full Text] [PDF]

				V. P.C.C. Yu, M. Koehler, C. Steinlein, M. Schmid, L. A. Hanakahi, A. J. van Gool, S. C. West, and A. R. Venkitaraman Gross chromosomal rearrangements and genetic exchange between nonhomologous chromosomes following BRCA2 inactivation Genes & Dev., June 1, 2000; 14(11): 1400 - 1406. [Abstract] [Full Text]

				B. I. Sigbjörnsdottir, G. Ragnarsson, B. A. Agnarsson, C. Huiping, R. B. Barkardottir, V. Egilsson, and S. Ingvarsson Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer J. Med. Genet., May 1, 2000; 37(5): 342 - 347. [Abstract] [Full Text]

				N. J. Marston, W. J. Richards, D. Hughes, D. Bertwistle, C. J. Marshall, and A. Ashworth Interaction between the Product of the Breast Cancer Susceptibility Gene BRCA2 and DSS1, a Protein Functionally Conserved from Yeast to Mammals Mol. Cell. Biol., July 1, 1999; 19(7): 4633 - 4642. [Abstract] [Full Text] [PDF]

				S. Ingvarsson, B. A. Agnarsson, B. I. Sigbjornsdottir, J. Kononen, O.-P. Kallioniemi, R. B. Barkardottir, A. J. Kovatich, R. Schwarting, W. W. Hauck, K. Huebner, et al. Reduced Fhit Expression in Sporadic and BRCA2-linked Breast Carcinomas Cancer Res., June 1, 1999; 59(11): 2682 - 2689. [Abstract] [Full Text] [PDF]

				A Suzuki, J L de la Pompa, R Hakem, A Elia, R Yoshida, R Mo, H Nishina, T Chuang, A Wakeham, A Itie, et al. Brca2 is required for embryonic cellular proliferation in the mouse. Genes & Dev., May 15, 1997; 11(10): 1242 - 1252. [Abstract] [PDF]

				T. A. Sellers Genetic Factors in the Pathogenesis of Breast Cancer: Their Role and Relative Importance J. Nutr., May 1, 1997; 127 (5): 929S - 929S. [Abstract] [Full Text] [PDF]

				J. V. Rajan, M. Wang, S. T. Marquis, and L. A. Chodosh Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells PNAS, November 12, 1996; 93(23): 13078 - 13083. [Abstract] [Full Text] [PDF]